| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
TearLab Corp (TSE: TLB)
TLB Technical Analysis
5
| As on 31st Oct 2017 TLB Share Price closed @ 1.76 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.05 & Strong Sell for SHORT-TERM with Stoploss of 2.11 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TLB Share Price
| Open | 1.79 | Change | Price | % |
| High | 1.80 | 1 Day | -0.05 | -2.76 |
| Low | 1.75 | 1 Week | 0.00 | 0.00 |
| Close | 1.76 | 1 Month | 0.01 | 0.57 |
| Volume | 3802 | 1 Year | 1.01 | 134.67 |
| 52 Week High 7.43 | 52 Week Low 0.51 | ||||
TSE Canada Most Active Stocks
| BIN | 41.40 | -1.62% |
| LSG | 2.08 | 8.33% |
| TBE | 0.03 | 0.00% |
| ECA | 15.09 | 4.43% |
| SC | 60.83 | -0.44% |
| PRE | 0.64 | 0.00% |
| ELD | 1.62 | -6.90% |
| MFC | 25.94 | -0.04% |
| CPG | 10.61 | 4.53% |
| BBD-B | 2.73 | -1.09% |
TSE Canada Top Gainers Stocks
TSE Canada Top Losers Stocks
| TLB Daily Charts |
TLB Intraday Charts |
Whats New @ Bazaartrend |
TLB Free Analysis |
|
|
TLB Important Levels Intraday
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
| RESISTANCE | 1.81 |
| RESISTANCE | 1.79 |
| SUPPORT | 1.73 |
| SUPPORT | 1.71 |
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
TLB Target for Month February
| 4th UP TARGET | 3.57 |
| 3rd UP TARGET | 2.99 |
| 2nd UP TARGET | 2.63 |
| 1st UP TARGET | 2.27 |
| 1st DOWN TARGET | 1.25 |
| 2nd DOWN TARGET | 0.89 |
| 3rd DOWN TARGET | 0.53 |
| 4th DOWN TARGET | -0.05 |
TLB Weekly Target
| 4th UP TARGET | 0.00 |
| 3rd UP TARGET | 0.00 |
| 2nd UP TARGET | 0.00 |
| 1st UP TARGET | 0.00 |
| 1st DOWN TARGET | 0.00 |
| 2nd DOWN TARGET | 0.00 |
| 3rd DOWN TARGET | 0.00 |
| 4th DOWN TARGET | 0.00 |
TLB Target for Year 2021
| 4th UP TARGET | 0 |
| 3rd UP TARGET | 0 |
| 2nd UP TARGET | 0 |
| 1st UP TARGET | 0 |
| 1st DOWN TARGET | 0 |
| 2nd DOWN TARGET | 0 |
| 3rd DOWN TARGET | 0 |
| 4th DOWN TARGET | 0 |
TearLab Corp ( TSE Canada Symbol : TLB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TLB Business Profile
TearLab Corp. operates as an ophthalmic device company in the United States. It is involved in developing and commercializing TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. The companyÂ’s system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, which is a single-use microfluidic microchip; TearLab pen, which is a hand-held device that interfaces with the TearLab disposable; and TearLab reader, which is a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corp. was founded in 1996 and is headquartered in San Diego, California.
© 2005-2019 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
